Drug Combination Details
General Information of the Combination (ID: C38943) | |||||
---|---|---|---|---|---|
Name | Genistein NP Info | + | Tamoxifen Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Breast cancer
[ICD-11: 2C60]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Down-regulation | Expression | EGFR | Molecule Info |
Pathway MAP
|
|
Down-regulation | Expression | ESR | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | HER2 | Molecule Info |
Pathway MAP
|
||
In-vitro Model | BT-474 | CVCL_0179 | Invasive breast carcinoma | Homo sapiens | ||
Experimental
Result(s) |
Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-overexpressing human breast cancer cells. | |||||
Experiment 2 Reporting the Effect of This Combination | [2] | |||||
In-vitro Model | MDA-MB-435 | CVCL_0417 | Breast cancer | Homo sapiens | ||
Experimental
Result(s) |
Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells. |



